Belch AR - Search Results

1

CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. Treon SP, et al. Among authors: belch ar. J Immunother. 2002 Jan-Feb;25(1):72-81. doi: 10.1097/00002371-200201000-00008. J Immunother. 2002. PMID: 11924912 Clinical Trial.

2

Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.

Treon SP, Shima Y, Preffer FI, Doss DS, Ellman L, Schlossman RL, Grossbard ML, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: belch ar. Semin Oncol. 1999 Oct;26(5 Suppl 14):97-106. Semin Oncol. 1999. PMID: 10561024

3

Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens.

Treon SP, Shima Y, Grossbard ML, Preffer FI, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: belch ar. Ann Oncol. 2000;11 Suppl 1:107-11. Ann Oncol. 2000. PMID: 10707790 Review.

4

Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.

Pilarski LM, Belch AR. Pilarski LM, et al. Among authors: belch ar. Clin Cancer Res. 2002 Oct;8(10):3198-204. Clin Cancer Res. 2002. PMID: 12374689

5

SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.

Taylor BJ, Reiman T, Pittman JA, Keats JJ, de Bruijn DR, Mant MJ, Belch AR, Pilarski LM. Taylor BJ, et al. Among authors: belch ar. J Immunother. 2005 Nov-Dec;28(6):564-75. doi: 10.1097/01.cji.0000175685.36239.e5. J Immunother. 2005. PMID: 16224274

6

In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.

Debes Marun CS, Belch AR, Pilarski LM. Debes Marun CS, et al. Among authors: belch ar. Am J Hematol. 2012 Jun;87(6):579-87. doi: 10.1002/ajh.23194. Epub 2012 Apr 12. Am J Hematol. 2012. PMID: 22495885 Free PMC article.

7

Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma.

Pilarski LM, Szczepek AJ, Belch AR. Pilarski LM, et al. Among authors: belch ar. Blood. 1997 Nov 1;90(9):3751-9. Blood. 1997. PMID: 9345062 Free article.

8

Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone.

Treon SP, Mollick JA, Urashima M, Teoh G, Chauhan D, Ogata A, Raje N, Hilgers JH, Nadler L, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: belch ar. Blood. 1999 Feb 15;93(4):1287-98. Blood. 1999. PMID: 9949172 Free article.

9

Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.

Pilarski LM, Mant MJ, Belch AR. Pilarski LM, et al. Among authors: belch ar. Leuk Lymphoma. 1999 Jan;32(3-4):199-210. doi: 10.3109/10428199909167381. Leuk Lymphoma. 1999. PMID: 10037018 Review.

10

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma.

Treon SP, Maimonis P, Bua D, Young G, Raje N, Mollick J, Chauhan D, Tai YT, Hideshima T, Shima Y, Hilgers J, von Mensdorff-Pouilly S, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: belch ar. Blood. 2000 Nov 1;96(9):3147-53. Blood. 2000. PMID: 11049996 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters